Spectrum Pharma's blood cancer drug meets goal in mid-stage trial

(Reuters) - Spectrum Pharmaceuticals Inc said a mid-stage trial of its experimental blood cancer drug met the main goal of shrinking tumors. The drug, belinostat, was tested in patients with relapsed/refractory peripheral T-Cell (PTCL) lymphoma, w...

Source: http://health.yahoo.net/news/s/nm/spectrum-pharma-s-blood-cancer-drug-meets-goal-in-mid-stage-trial

home homepage view homepage homepage here